Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Sales/Fixed Asset

    Back to All Ratios
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Sales/Fixed Asset History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 1.421.571.261.020.93

What is the latest Sales/Fixed Asset ratio of BAFNA PHARMACEUTICALS ?

The latest Sales/Fixed Asset ratio of BAFNA PHARMACEUTICALS is 1.42 based on Mar2025 Standalone results.
Year Sales/Fixed Asset
Mar20251.42
Mar20241.57
Mar20231.26
Mar20221.02
Mar20210.93

How is Sales/Fixed Asset of BAFNA PHARMACEUTICALS Trending?

Years Sales/Fixed Asset % Change
Mar2025 1.42
-9.55
Mar2024 1.57
24.60
Mar2023 1.26
23.53
Mar2022 1.02
9.68
Mar2021 0.93 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Sales/Fixed Asset ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹244.2 Cr -3.2% -20.6% 21.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,693.0 Cr -1.7% 4% 11.8% Stock Analytics
DIVIS LABORATORIES ₹161,270.0 Cr -4.7% -1.8% 10.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,281.0 Cr -3.7% 4.5% 42.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,422.0 Cr -3% 0% 15.4% Stock Analytics
CIPLA ₹104,915.0 Cr -2.6% -2.3% -10.1% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-3.2%

-20.6%

21.2%

SENSEX

-2.7%

-10.4%

1.6%


You may also like the below Video Courses